Oliver Burk

9.8k total citations · 3 hit papers
68 papers, 8.0k citations indexed

About

Oliver Burk is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Oliver Burk has authored 68 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 38 papers in Pharmacology and 16 papers in Molecular Biology. Recurrent topics in Oliver Burk's work include Drug Transport and Resistance Mechanisms (38 papers), Pharmacogenetics and Drug Metabolism (36 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Oliver Burk is often cited by papers focused on Drug Transport and Resistance Mechanisms (38 papers), Pharmacogenetics and Drug Metabolism (36 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Oliver Burk collaborates with scholars based in Germany, United States and Sweden. Oliver Burk's co-authors include Michel Eichelbaum, Anke Geick, Ulrich M. Zanger, Oliver von Richter, Ulrich Brinkmann, Matthias Schwab, Sven Hoffmeyer, Leszek Wojnowski, J. Brockmöller and Ivar Roots and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Oliver Burk

66 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

2000 2.0k citations Oliver Burk, Michel Eichelbaum et al. profile →
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin

2001 702 citations Michel Eichelbaum, Oliver Burk et al. profile →
The genetic determinants of the CYP3A5 polymorphism

2001 560 citations Oliver Burk, Renzo Wolbold et al. Pharmacogenetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Burk Germany	35	4.5k	3.4k	2.4k	1.9k	835	68	8.0k
Jatinder K. Lamba United States	41	3.6k 0.8×	3.7k 1.1×	2.2k 0.9×	2.1k 1.1×	625 0.7×	146	8.4k
Kathrin Klein Germany	44	2.9k 0.6×	3.6k 1.1×	1.3k 0.6×	1.8k 0.9×	636 0.8×	112	7.7k
Chantal Guillemette Canada	50	2.2k 0.5×	2.9k 0.9×	1.7k 0.7×	4.0k 2.1×	1.1k 1.3×	187	8.3k
Kazuto Yasuda United States	30	2.7k 0.6×	2.6k 0.8×	1.4k 0.6×	1.0k 0.5×	570 0.7×	59	5.4k
Elke Schaeffeler Germany	52	3.3k 0.7×	1.8k 0.5×	2.0k 0.8×	2.8k 1.5×	1.6k 1.9×	181	9.6k
Deanna L. Kroetz United States	46	3.1k 0.7×	1.9k 0.6×	1.4k 0.6×	3.1k 1.6×	501 0.6×	133	8.6k
Christian P. Strassburg Germany	59	2.2k 0.5×	2.3k 0.7×	1.7k 0.7×	2.9k 1.5×	731 0.9×	355	13.0k
Ichiro Ieiri Japan	45	3.3k 0.7×	2.1k 0.6×	1.9k 0.8×	1.2k 0.6×	195 0.2×	176	6.4k
Satohiro Masuda Japan	49	4.6k 1.0×	943 0.3×	2.9k 1.2×	1.9k 1.0×	323 0.4×	191	8.8k
Jörg König Germany	55	8.1k 1.8×	1.9k 0.6×	4.2k 1.8×	2.3k 1.2×	328 0.4×	128	10.9k

Countries citing papers authored by Oliver Burk

Since Specialization

Citations

This map shows the geographic impact of Oliver Burk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Burk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Burk more than expected).

Fields of papers citing papers by Oliver Burk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Burk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Burk. The network helps show where Oliver Burk may publish in the future.

Co-authorship network of co-authors of Oliver Burk

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Burk. A scholar is included among the top collaborators of Oliver Burk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Burk. Oliver Burk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Klein, Kathrin, Oliver Burk, Roman Tremmel, et al.. (2025). Transcription factors of the Nuclear Factor I (NFI) family control hepatocyte differentiation and cytochrome P450 activity in human liver. Pharmacological Research. 221. 107998–107998.

2.

Lee, Serene M. L., et al.. (2021). Identification and characterization of novel splice variants of human farnesoid X receptor. Archives of Biochemistry and Biophysics. 705. 108893–108893. 9 indexed citations

3.

Riedmaier, Arian Emami, Oliver Burk, Elke Schaeffeler, et al.. (2015). Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors. The Pharmacogenomics Journal. 16(4). 341–351. 34 indexed citations

4.

Nüssler, Andreas K., Wolfgang E. Thasler, Kathrin Klein, et al.. (2015). Human Sterol Regulatory Element-Binding Protein 1a Contributes Significantly to Hepatic Lipogenic Gene Expression. Cellular Physiology and Biochemistry. 35(2). 803–815. 25 indexed citations

5.

Thomas, Maria, Oliver Burk, Benjamin A. Kandel, et al.. (2013). Direct Transcriptional Regulation of Human Hepatic Cytochrome P450 3A4 (CYP3A4) by Peroxisome Proliferator–Activated Receptor Alpha (PPARα). Molecular Pharmacology. 83(3). 709–718. 73 indexed citations

6.

Nies, Anne T., Mikko Niemi, Oliver Burk, et al.. (2013). Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1. Genome Medicine. 5(1). 1–1. 208 indexed citations

7.

Hauser, I.A., Stephan Kruck, Stefan Gauer, et al.. (2012). Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation. Clinical Pharmacology & Therapeutics. 91(5). 905–916. 16 indexed citations

8.

Burk, Oliver, et al.. (2012). Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms. British Journal of Pharmacology. 167(3). 666–681. 30 indexed citations

9.

Istrate, Monica A., Andreas K. Nüssler, Michel Eichelbaum, & Oliver Burk. (2010). Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding. Biochemical and Biophysical Research Communications. 393(4). 688–693. 39 indexed citations

10.

Nies, Anne T., Hermann Koepsell, Stefan Winter, et al.. (2009). Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†. Hepatology. 50(4). 1227–1240. 306 indexed citations

11.

Gradhand, Ulrike, Heike Tegude, Oliver Burk, et al.. (2007). Functional analysis of the polymorphism −211C>T in the regulatory region of the human ABCC3 gene. Life Sciences. 80(16). 1490–1494. 20 indexed citations

12.

Wehkamp, Jan, Guoxing Wang, Irmgard Kübler, et al.. (2007). The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-4. The Journal of Immunology. 179(5). 3109–3118. 220 indexed citations

13.

Lang, Thomas, Monika Hitzl, Oliver Burk, et al.. (2004). Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics. 14(3). 155–164. 81 indexed citations

14.

Eichelbaum, Michel, et al.. (2004). Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. PubMed. 2(1). 1–1. 72 indexed citations

15.

Glaeser, Hartmut, Siegfried Drescher, Oliver Burk, et al.. (2001). Induction of CYP2C8, CYP2C9, and CYP3A4 by rifampin in shedded human enterocytes.. Drug Metabolism Reviews. 33. 90. 1 indexed citations

16.

Sperker, Bernhard, Céline Tomkiewicz, Oliver Burk, Robert Barouki, & Heyo K. Kroemer. (2001). Regulation of Human β-Glucuronidase by A23187 and Thapsigargin in the Hepatoma Cell Line HepG2. Molecular Pharmacology. 59(2). 177–182. 1 indexed citations

17.

Sperker, Bernhard, Céline Tomkiewicz, Oliver Burk, Robert Barouki, & Heyo K. Kroemer. (2001). Regulation of Human β-Glucuronidase by A23187 and Thapsigargin in the Hepatoma Cell Line HepG2. Molecular Pharmacology. 59(2). 177–182. 16 indexed citations

18.

Fromm, Martin F., Hans-Martin Kauffmann, Péter Fritz, et al.. (2000). The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters. American Journal Of Pathology. 157(5). 1575–1580. 208 indexed citations

19.

Worpenberg, Susanne, Oliver Burk, & Karl‐Heinz Klempnauer. (1997). The chicken adenosine receptor 2B gene is regulated by v-myb. Oncogene. 15(2). 213–221. 25 indexed citations

20.

Burk, Oliver. (1997). tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells. The EMBO Journal. 16(6). 1371–1380. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact